Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_3
1
20%
Ph phase_4
3
60%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting1
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 43 (60.0%)

Trials by Status

not_yet_recruiting120%
unknown240%
completed120%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_4

The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery

NCT05714007
not_yet_recruitingphase_4

Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients

NCT06830941
unknownphase_3

A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

NCT05784870
unknownphase_2

Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)

NCT03891277
completedphase_4

the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients

NCT02631668

Clinical Trials (5)

Showing 5 of 5 trials
NCT05714007Phase 4

The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery

Recruiting
NCT06830941Phase 4

Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients

Not Yet Recruiting
NCT05784870Phase 3

A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

Unknown
NCT03891277Phase 2

Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)

Unknown
NCT02631668Phase 4

the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5